August 2020 Table Of Contents - Usaid.gov
USAID/OFDA Application GuidelinesPharmaceutical & Medical Commodity GuidanceAugust 2020Table of ContentsIntroduction1Definitions2Procedures to Purchase Pharmaceuticals and Medical Commodities5Human Essential Medicines List (EML)Alphabetical Listing of Pharmaceutical ProductsVeterinary Essential Medicines List111329Alphabetical Listing of Veterinary Drugs31Alphabetical Listing of Veterinary Vaccine32Prequalified Pharmaceutical Vendors36Post-Award Assistance37Indicators – Intent and How to Report37Disposition of Pharmaceuticals39Disposition of Medical Equipment and Medical Supplies39IntroductionYou must follow this guidance to purchase medical commodities with USAID/BHAfunds, including pharmaceuticals (human or veterinary), medical equipment, and/ormedical supplies. All medical commodities are reviewed for appropriateness for theactivity, for the situation, and for the country. In addition, pharmaceuticals are a USAIDrestricted good and have more rigorous review and approval procedures to ensuresafety, effectiveness, and quality of the products when provided to beneficiaries.Not all pharmaceuticals are allowable with USAID/BHA funding. The following aregenerally NOT funded by USAID/BHA, so contact BHA if you intent to include them. Antiretroviral medicines (ARVs) or RDTs for HIV/AIDS. Requests for these itemsmust be coordinated with the President’s Emergency Program for AIDS Relief(PEPFAR) program; Anti-tuberculosis medicines; and Contraceptives and condoms – Requests for these items must be coordinatedwith USAID’s Office of Population and Reproductive Health (PRH)
DefinitionsBiological: Products derived from living organisms, including immunobiologicals (suchas vaccines), hormones, and blood products (immunoglobulins, albumin, etc.).Disposition: This term refers to what happens to the pharmaceuticals and medicalcommodities purchased for the activity that remain unused when your organizationdetermines there is no longer a need or the award is completed. There are three formsof disposition:Donation: The giving of pharmaceuticals and/or medical commodities from oneentity (NGO, PIO, or host nation) to another free of charge.Transfer: The movement of pharmaceuticals and/or medical commodities from oneproject to another within the same organization.Destruction: The rendering of the pharmaceuticals and/or medical commoditiesunfit for human or veterinary medical use. (This is usually because the commoditieshave been damaged or are expired.)FDA-Licensed Products: This term refers to products approved by the U.S. Food andDrug Administration (FDA) for market use in the United States that have been producedin a manufacturing facility inspected and licensed by the FDA. FDA-approved productsmay be manufactured in a non-U.S. facility provided that the facility has been inspectedand meets FDA requirements. The FDA is comprised of six centers, each of whichoversee specific product areas: Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, Center for Drug Evaluation and Research, Center for Food Safety and Applied Nutrition, Center for Tobacco Products, and Center for Veterinary Medicine.Kit: A generic term referring to a collection of pharmaceuticals, supplies, and/orequipment for a specific purpose. Kits often contain USAID-restricted commoditiessuch as oral rehydration salts (ORS) or other pharmaceuticals.Kits may be Internationally recognized and standardized (e.g., the World HealthOrganization’s [WHO] Interagency Emergency Health Kit, frequently referred toas IEHK, or the Interagency Reproductive Health Kits for Crisis Situations), or Unique, non WHO-standardized (e.g., hygiene kits, first aid kits, communityanimal health worker kits).Medical Commodities: A collective term to include pharmaceuticals, consumablemedical supplies, and durable medical equipment.Medical Equipment (Durable): This term refers to commodities designed for humansor animals that may generally be reused after proper cleaning and disinfection. Medicalequipment includes but is not limited to Sphygmomanometers Exam tables Surgical equipmentUSAID/BHA Pharmaceutical Guidancepg. 2
EKG machines Weighing scales for animals or humans Animal hoof knives or trimmersMedical Supplies (Consumables): This term refers to commodities that are disposedof after treating a patient or animal. Medical supplies include, but are not limited to,such items as Single-use syringes Bandages Tongue depressor blades Suture materials Surgical and exam glovesNon-Prequalified Pharmaceutical Vendors: These are pharmaceutical vendors thathave not been audited and approved by USAID. Although these vendors may in factcarry safe, effective, quality human and/or veterinary pharmaceuticals and vaccines, acase-by-case evaluation must be made. This stringent process may take weeks, if notmonths, to complete and is dependent upon how quickly required documentation fromvendors is provided to USAID/BHA for review.Oral Rehydration Salts (ORS): A glucose-based salt solution used to treat or preventdehydration from diarrhea from any cause, including cholera, and in individuals of anyage.Pharmaceutical: As defined in USAID’s Automated Directives System (ADS)Glossary, a pharmaceutical is any substance intended for use in the diagnosis, cure,mitigation, treatment, or prevention of diseases in humans or animals; any substance(other than food) intended to affect the structure or any function of the bodies of humansor animals; and any substance intended for use as a component in the above. The termincludes Drugs Vitamins ORS Biologicals Certain in-vitro diagnostic test kits (e.g., Rapid Diagnostic Tests [RDTs]).Devices or their components, parts, or accessories are not included. If a kit or modulecontains any pharmaceutical(s), the whole kit or module is considered apharmaceutical. See ADS 312 for more information.Prequalified Pharmaceutical Vendors: Pharmaceutical vendors that have beenaudited by USAID/BHA and found to have met internationally accepted standards forsafe, effective, and quality pharmaceuticals and approved by USAID/BHA for recipientsto procure from. This list is dynamic, you are advised to refer to the updated list ofPrequalified Pharmaceutical Vendors prior to requesting pharmaceutical procurements.Rapid Diagnostic Tests (RDTs): A simple, fast way for health workers to test whethera person has a specific disease or condition (e.g., if a person with malaria-likesymptoms has malaria or if a non-menstruating female is pregnant).USAID/BHA Pharmaceutical Guidancepg. 3
Restricted Goods: For the purposes of the Pharmaceuticals and other MedicalCommodities Sub-Sector in the USAID/OFDA Application Guidelines, the followingmedical commodities are considered restricted goods by USAID: Human or Veterinary Pharmaceuticals, including vaccines, ORS, and intravenous(IV) fluids; Specific RDTs as cited on the USAID/BHA Human EML; and All kits or kit modules containing pharmaceuticals.Stringent Regulatory Authority (SRA): A drug regulatory body that closely resemblesthe FDA in standards utilized in its operations. Currently, countries that participate inthe International Conference on Harmonization (ICH) are considered SRAs. The ICHregulatory bodies include: United States Food and Drug Administration (FDA); Japanese Ministry of Health, Labor, and Welfare; European Medicines Agency (EMA) centralized procedure; European Free Trade Area (represented by the Swiss Medic); European Union member states admitted prior to 1996; and Australian Therapeutic Goods Administration (TGA).The Canadian drug regulatory authority, the Therapeutic Products Directorate, HealthCanada, is an observer to the ICH and is also considered a stringent regulatoryauthority.USAID/BHA Pharmaceutical Guidancepg. 4
Procedures to Purchase Pharmaceuticals and Medical CommoditiesIn order to purchase medical commodities for humans or animals with USAID/BHAfunds, including medical supplies, medical equipment, and/or pharmaceuticals, youmust follow this guidance in accordance with ADS 312. You must report the total costof each medical commodity type on a separate line in the budget spreadsheet of yourcost application.Pharmaceuticals: See the definition section of this document for more information onwhat is considered a pharmaceutical. For requests to purchase human or veterinarypharmaceuticals and/or kits containing pharmaceuticals, the following is required:A. All pharmaceuticals proposed for procurement must be within either theUSAID/BHA Human EML or Veterinary EML. Confirm products proposed forprocurement are on the lists.B. Provide an itemized list of the pharmaceutical products including the RDTs listedin the Human EML (e.g., cholera RDT, malaria RDT, or syphilis RDT) or any kitsthat contain pharmaceuticals (e.g., IEHK, Post Exposure Prophylaxis [PEP] kit,Interagency Reproductive Health kits for Crisis Situations, First Aid kits). See thePharmaceutical and Medical Commodities [PMC] Template which identifies therequired fields. The template contains several tabs. Place all products of thesame category on one tab (i.e., all human pharmaceuticals on one tab; all medicalsupplies on one tab; all medical equipment on one tab; and all veterinarypharmaceuticals on one tab). Submit only one PMC template for the application;do not submit multiple PMC templates based upon activity or location supported.Once all tabs are completed, save and submit the entire workbook in PDF format. The Overview tab describes the templates found on each tab; The Human Pharm, RDT, & Kit tab; The Vet Pharm & Kit tab; The Med Equipment tab; and The Med Supplies tab.C. Using the Human Pharm, RDT, & Kit tab of the templates, include the following: Your Organization’s Name; The Program title; The Country the activity is being implemented in; Proposed pharmaceutical vendor(s); Budget requested for only the procurement of the pharmaceuticals,exclusive of transportation or handling; Signature, printed name, and title of the individual responsible for theprocurement and oversight of pharmaceuticals, and a statement thati. Your organization is following all importation rules andrequirements, andii. Your organization has received or is working to receiveassurance that the host nation will allow the importation of thepharmaceuticals for use in the humanitarian response, withouttaxation or undue delay.Applicants must include on the list itself the following: International generic name of each pharmaceutical; Strength and dosage form;USAID/BHA Pharmaceutical Guidancepg. 5
Reason for use of the pharmaceutical within the activity. You mustprovide an explanation of why a specific pharmaceutical is being usedwithin the proposed activity. It is not the same as the pharmaceuticalproduct’s class or category. For example, an acceptable reason for theuse of amoxicillin would be for treatment of acute upper respiratoryinfections; whereas proposing the word “antibiotic” would not; Quantity. This is the number of unit-of-issue packages being requested; Unit-of-issue. This is how the vendor sells the product (e.g., bottle of 10,30, 100 or 1000 tablets; bottle of 480 mL; 10 vials each 2 mL of aninjectable product). It is NOT individual tablets or mL; Cost per unit-of-issue. This is how much each bottle of 10, 30, 1000tablets cost in USD, or bottle of 480 mL, or each box of 10 vials each 2mL of an injectable cost; Extended cost in USD. This is the quantity multiplied by cost per unit ofissue; and Total cost in USD of the amount for all pharmaceuticals on the list.D. Using the Vet Pharm & Kit tab of the templates, include the following: Your Organization’s Name; The Activity title; The Country the activity is being implemented in; Proposed pharmaceutical vendor(s); Budget requested for only the procurement of the pharmaceuticals,exclusive of transportation or handling; Printed name, position/title, and signature of the individual responsible forthe procurement and oversight of pharmaceuticals, and a statement thati. Your organization is following all importation rules andrequirements, andii. Your organization has received assurance that the host nationwill allow the importation of the pharmaceuticals for use in thehumanitarian response, without taxation or undue delay.The list itself must include International generic name and trade name of each pharmaceutical; Strength and dosage form; Condition the pharmaceutical will treat within the activity as well as thespecies of animal (e.g., oxytetracycline for foot rot in cattle); Quantity. This is the number of unit-of-issue packages to be requested; Unit-of-issue. This is how the vendor sells the product (e.g., bottle of 10,30, 100 or 1000 tablets; bottle of 480 mL; 10 vials each 2 mL of aninjectable product). It is NOT individual tablets or mL; Cost per unit-of-issue. This is how much each bottle of 10, 30, 1000 oftablets costs in USD, or bottle of 480 mL, or 10 vials each 2 mL of aninjectable cost; Extended cost in USD. This is the quantity multiplied by cost per unit ofissue; and Total cost. The amount in USD for all pharmaceuticals on the list.USAID/BHA Pharmaceutical Guidancepg. 6
E. If you seek USAID/BHA funds to purchase an internationally standardized andrecognized kit or kit module that contains pharmaceuticals, include Name of the kit or module Number of kits or modules being purchased Cost per kitF. If you seek USAID/BHA funds to purchase a kit that contains pharmaceuticalsand is not internationally standardized or recognized (i.e., hygiene kits, first aidkits, NFI kits), the individual products within the kit must be identified, to include Name of the kit Specific contents (see details below) Number of kits being purchased Cost per kit.On the Non-Standard Kits tabs of the PMC template, list the specific contents andquantity of each product found in the kit on a separate line. An example is shownon the PMC templates.Kits that do not contain pharmaceuticals but contain medical supplies or medicalequipment must be placed on the respective Med Supplies or Med Equipment tab.You must still state the contents of the non-standardized kits on the Non-StandardKits tab.G. If you are requesting to procure pharmaceutical products not found on either theHuman or Veterinary EML, describe why the specific product is required in theReason for Use column. In addition to the condition being treated, you mustinclude information such as1. Why products already on the Human or Veterinary EML are notacceptable;2. The proposed number of people or animals that will be treated with theproduct;3. The quantity required for each case (on average);4. If the service providers are familiar with using the product; and5. If the condition being treated was previously seen and how it was treated.H. If you are requesting to use a non-prequalified pharmaceutical vendor,documentation is required supporting the safety, efficacy, and quality of theproducts and the vendor. The process to approve a non-prequalifiedpharmaceutical vendor may take weeks or months depending on the informationthat is provided to USAID/BHA. The following documentation must be submittedin English:1. Name of the pharmaceutical vendor;2. Point of contact;3. Physical address;4. Phone number;5. Email address;6. Website;7. Government documents authorizing the sale of pharmaceuticals (i.e.,current licenses and/or permits);USAID/BHA Pharmaceutical Guidancepg. 7
8. The name of any organizations that have inspected the pharmaceuticalvendor within the past 24 months and a copy of the inspection or audit;9. A copy of the vendor’s standard operating procedures related to theirquality assurance program;10. A copy of the vendor’s standard operating procedures related to theirprocess used to select inventory of the vendor;11. Availability of certificates of analysis for each batch of eachpharmaceutical product purchased;12. Assurance from the vendor that all pharmaceuticals meet internationalstandards for quality, safety, and efficacy;13. Assurance that the vendor’s expiration policy states that nopharmaceuticals will be sold within 12 months prior to the expiration date;and14. Photographs of exterior of the vendor’s facility (i.e., storefront and/orwarehouse), interior storage areas, exterior signage, windows, deliveryand shipping docks, cold storage facility, temperature monitors, shelvingsystems, and pest control measures.Other Medical Commodities: USAID/BHA reviews the appropriateness of the amountand types of medical supplies and medical equipment being requested to ensure yourorganization’s funding request matches the response situation and the proposed healthintervention(s).Requests to purchase human or veterinary medical supplies and/or medical equipmentmust be provided separately (e.g., one list of medical supplies, a separate list of medicalequipment). USAID/BHA requires applicants to use the PMC Templates to addressUSAID/BHA requirements. The PMC template has separate tabs for each medicalcommodity type. A list of medical supplies would be requested on the medical suppliestab; similarly a list of medical equipment would be requested on the medical equipmenttab.If you seek USAID/BHA funds to purchase a kit or kit module that does NOT containany pharmaceuticals but does contain items considered to be medical supplies ormedical equipment (e.g., first aid kits, surgical equipment kits, community animal healthworker kit), you must make the request on the respective Med Supplies or MedEquipment tab of the PMC templates depending on the majority of the components. Forexample, if most of the components would be considered medical supplies, as in a firstaid kit, then list the kit on the Med Supplies tab of the PMC template. If most of thecomponents are considered medical equipment, as in a surgical equipment kit, then listthe kit on the Med Equipment tab of the PMC template. Specify the contents of the kiton the Non-Standard Kit tab of the PMC template.You must identify each request with your organization’s name, activity title, total cost ofthe commodity type, and date of submission of the list.Each list on the appropriate tab of the PMC template must include the followinginformation:1. Medical supplies (also known as consumables). This includes laboratorysupplies (e.g., reagents, glassware, solutions) or RDTs not on the human EML.USAID/BHA Pharmaceutical Guidancepg. 8
The total cost must be entered on a separate line in the budget and markedaccordingly. Using the Med Supplies tab of the templates, provide a detailed listof medical supplies with:a. Item nameb. Quantityc. Total cost for the productd. Total cost for all medical supplies.2. Medical equipment (also known as durable). This includes laboratory equipment(e.g., microscopes, autoclaves, hoof trimmers). The total cost must be enteredon a separate line in the budget and marked accordingly. Using the MedEquipment tab of the templates, provide a detailed list of medical equipment with:a. Item name;b. Quantity;c. Total cost for the piece of equipment. If a single piece of medicalequipment costs 5,000 USD or more, other requirements apply; see thenext section for additional details; andd. Total cost for all medical equipment.Once you complete all tabs, save and submit the entire signed workbook in PDF format.Additional Requirements for Medical Equipment Valued at or Above 5,000 USDIn the application budget: In addition to including medical equipment in the PMCtemplates, any individual piece of equipment valued at or above 5,000 USD must belisted on an individual line in the activity budget under the “capital equipment budgetcategory/equipment at or greater than 5,000 USD.” Please refer to the USAID/BHAsample budget for reference.In the application narrative: Any (medical) equipment valued at or above 5,000 USDrequires additional information in the application narrative, PMC sub-sector, including The need for the medical equipment; The specifications for the medical equipment; Experience of healthcare personnel who will use the medical equipment; and Arrangements for training, maintenance, and spare parts.Table showing which tab to use in the Pharmaceuticals and other MedicalCommodities (PMC) templatesThe product is:Human Pharmaceutical(i.e., Amoxicillin, oralrehydration salts,malaria rapid diagnostictest)VeterinaryPharmaceutical (i.e.,Amitraz, fenbendazole,tick grease)HumanPharmaceuticals, RapidDiagnostic Tests, andKits/Modules containingPharmaceuticalsMedical EquipmentMedical SuppliesVeterinaryPharmaceuticals andKits/Modules containingVeterinaryPharmaceuticalsxxUSAID/BHA Pharmaceutical Guidancepg. 9
Either a human orveterinary piece of(medical) equipment(i.e., stethoscope,thermometer, weighingscale for baby, horntrimmer)Either a human orveterinary consumable(medical) supply (i.e.,gauze, disposablegloves, disposablesyringes)A Kit that containshuman pharmaceuticalsAND medicalequipment and/orsupplies (i.e., IEHK[basic] 2017, First aidkit that hasparacetamol, ORS,gauze, and bandages)A kit that has veterinarypharmaceuticals AND(medical) equipmentand/or supplies (i.e.,CAHW kit withmultivitamins,trimethoprim,disposable syringesand needles,thermometer)A kit that has no humanor veterinarypharmaceuticals, butdoes has medicalequipment (i.e., surgicalblades, forceps,retractors, kidneybasins)A kit that has no humanor veterinarypharmaceuticals butdoes have consumable(medical) supplies (i.e.,gauze, bandages,disposable syringesand needles,disposable gloves)xxxxxxUSAID/BHA Pharmaceutical Guidancepg. 10
Human Essential Medicines List (EML)USAID/BHA has a Human Essential Medicines List (Human EML) and a separateVeterinary EML.The Human EML is intended to1. Simplify the pharmaceutical selection process,2. Expedite the pharmaceutical approval process, and3. Maximize USAID/BHA resources to provide the greatest amount of assistance tothe greatest number of beneficiaries possible.Pharmaceuticals requested for USAID/BHA-supported health activities are reviewed forappropriateness for the health intervention, the situation, and the country in addition tosafety, efficacy, and quality. A pharmaceutical product’s inclusion on the Human EMLdoes NOT convey blanket approval for use. The Human EML is expected to treat themajority of the medical conditions encountered in USAID/BHA-supported healthactivities, although there may be exceptions. References for the Human EML includethe WHO Model Lists for Essential Medicines, WHO Standard Emergency Health Kits,and the Inter-Agency Reproductive Health Kits for Crisis Situations, among others.USAID/BHA does not traditionally support pharmaceuticals supplied by nationalprograms, such as the expanded program for immunization (EPI) or programs focusingon family planning, HIV/AIDS, or tuberculosis.Where appropriate, USAID/BHA supports pharmaceutical needs being met through useof the most current internationally standardized and recognized pharmaceutical kits ormodules (e.g., IEHK; or Interagency Reproductive Health kits for Use in Crisissituations). Prolonged crisis or complex emergency projects should not continue to relyon the use of large standardized kits, but should evolve to a more targeted approach tothe situation.Using the Human EMLThe USAID/OFDA Application Guidelines provide information on what is required whensubmitting a request to USAID/BHA to purchase pharmaceuticals.You must base your selection of pharmaceuticals on the Human EML. The proposedpharmaceuticals and the proposed reason for use will be reviewed for appropriatenessfor the proposed activity. It is important to note, within the Human EML, there are aspecial group of pharmaceuticals known as ‘Restricted Use Pharmaceuticals’. This isthe only use that should be written in the Reason for Use column of the template. If oneof these products is needed to treat another indication, a detailed explanationsupporting that reason must be submitted. Procurement of the pharmaceutical for the‘non-restricted use’ indication is not allowed unless approved.BHA supports procurement of some internationally standardized kits or kit modules,including WHO standard emergency health kits and Interagency Reproductive HealthKits for Crisis Situations. As these kits and modules are frequently updated, pleaseconsult BHA for kits or modules that are currently supported.USAID/BHA Pharmaceutical Guidancepg. 11
If you wish to purchase pharmaceuticals that are not on the Human EML or request analternative use for one designated as a restricted-use product (noted below highlightedin yellow), you must request an exception by providing the following information:1. Submit a request explaining the need based upon a specific disease conditionand data;2. Your organization’s headquarters-level responsible physician must sign, asindicated in the USAID/OFDA Application Guidelines;3. Within your request, separate justifications are required for each pharmaceuticalproduct for which you seek exemption;4. Requests for exception (and supporting justifications) must be submitted eachtime the procurement of the product is requested;5. Review of the exception(s) may slow the overall approval process and does notguarantee approval. If an exception is approved, you may proceed withprocurement; and6. You must track in your activity performance reports the use of any product with arestricted use indication and/or any non-USAID/BHA Human EML productincluding the number of patients treated for the specific indication.USAID/BHA Pharmaceutical Guidancepg. 12
Alphabetical Listing of Pharmaceutical ProductsRestricted products highlighted in yellowProduct NameEML Category Number(s)AcetazolamideEML 21Acetylsalicylic acid EML 2 1; EML 12AcyclovirEML 6 4; EML 21Adrenalinesee EpinephrineAlbendazoleEML 6 1AmitriptylineEML 2 3; EML 24AmlodipineEML 12AmodiaquineEML 6 5 3AmoxicillinEML 6 2Amoxicillin clavulanic acid EML 6 2Amphotericin B EML 6 3; EML 6 5 2AmpicillinEML 6 2ArtemetherEML 6 5 3Artemether lumefantrine EML 6 5 3ArtesunateEML 6 5 3Artesunate amodiaquine EML 6 5 3Artesunate mefloquine EML 6 5 3Ascorbic acidEML 27AtenololEML 12AtracuriumEML 20AtropineEML 1 3; EML 4; EML 21AzithromycinEML 6 2BeclomethasoneEML 25Benzathine benzylpenicillin EML 6 2BenznidazoleEML 6 5 4Benzyl benzoateEML 13BenzylpenicillinEML 6 2BetamethasoneEML 13BisoprololEML 12BudesonideEML 25BupivacaineEML 1 2CalamineEML 13Calcium gluconateEML 4CarbamazepineEML 5; EML 24CarvedilolEML 12CefalexinEML 6 2CefazolinEML 6 2CefiximeEML 6 2CeftriaxoneEML 6 2Charcoal, activatedEML 4ChloramphenicolEML 6 2ChloroquineEML 6 5 3ChlorpheniramineEML 3ChlorpromazineEML 24Cholera Rapid Diagnostic Test (RDT)EML 0CiprofloxacinEML 6 2Product NameEML Category Number(s)ClopidogrelEML 12ClotrimazoleEML 6 3CloxacillinEML 6 2CyclopentolateEML 21DexamethasoneEML 2 3; EML 3;EML 17Diazepam EML 2 3; EML 5; EML 24DicloxacillinEML 6 2DiethylcarbamazineEML 6 1DigoxinEML 12DiloxanideEML 6 5 1DocusateEML 2 3; EML 17DoxycyclineEML 6 2; EML 6 5 3EflornithineEML 6 5 4EnalaprilEML 12EnoxaparinEML 10Epinephrine EML 3;EML 12; EML 25ErgometrineEML 22ErythromycinEML 6 2Ferrous saltEML 10Ferrous salt folic acidEML 10FluconazoleEML 6 3FluoresceinEML 14FluoxetineEML 2 3; EML 24Folic acidEML 10FurosemideEML 12; EML 16GentamicinEML 6 2; EML 21Glibenclamide (glyburide)EML 18GliclazideEML 18GlucagonEML 18GlucoseEML 26Glucose with sodium chloride EML 26USAID/BHA Pharmaceutical Guidancepg. 13
Glyceryl trinitrateEML 12HaloperidolEML 2 3; EML 24HalothaneEML 1 1HeparinEML 10HomatropineEML 21HydralazineEML 12Hydrochlorothiazide (HCTZ)EML 12;EML 16HydrocortisoneEML 3; EML 13HydroxocobalaminEML 10HyoscineEML 2 3; EML 17Product NameEML Category Number(s)IbuprofenEML 2 1Insulin (soluble)EML 18Insulin, intermediate actingEML 18Ipratropium bromideEML 25IsofluraneEML 1 1Isosorbide dinitriteEML 12IvermectinEML 6 1KetamineEML 1 1LevothyroxineEML 18LidocaineEML 1 2; EML 12Lidocaine epinephrineEML 1 2Lithium carbonateEML 24LoratadineEML 3LorazepamEML 5Magnesium sulfateEML 5Malaria Rapid Diagnostic Test (RDT)EML 0MebendazoleEML 6 1MefloquineEML 6 5 3Meglumine antimoniateEML 6 5 2MelarsoprolEML 6 5 4MetforminEML 18MethyldopaEML 12MetoclopramideEML 2 3; EML 17MetoprololEML 12Metronidazole EML 6 2;EML 6 5 1MiconazoleEML 13MidazolamEML 1 3; EML 2 3; EML 5MiltefosineEML 6 5 2MisoprostolEML 22MorphineEML 1 3; EML 2 NifurtimoxNitrofurantoinNitroglycerinNitrous oxideNystatinOfloxacinEML 21OmeprazoleEML 13EML 4EML 20EML 6 1EML 22EML 6 5 4EML 6 2See Glyceryl trinitrateEML 1 1EML 6 3EML 17Product NameEML Category Number(s)OndansetronEML 2 3;EML 17Oral rehydration salts (ORS) EML 17;EML 26OxytocinEML 22ParacetamolEML 2 1ParomomycinEML 6 5 2PentamidineEML 6 5 4PermethrinEML 13PhenobarbitalEML 5PhenoxymethylpenicillinEML 6 2PhenytoinEML 5PhytomenadioneEML 10PilocarpineEML 21Potassium ChlorideEML 26Potassium iodideEML 18Potassium permanganateEML 13PraziquantelEML 6 1PrednisoloneEML 3; EML 21PrednisoneEML 3PrimaquineEML 6 5 3Procaine benzylpenicillinEML 6 2ProguanilEML 6 5 3PropofolEML 1 1PropylthiouracilEML 18Protamine sulfateEML 10PyrantelEML 6 1QuinineEML 6 5 3RetinolEML 27USAID/BHA Pharmaceutical Guidancepg. 14
RisperidoneEML 24SalbutamolEML 25Selenium sulfideEML 13SennaEML 2 3; EML 17Silver sulfadiazineEML 13SimvastatinEML 12Sodium chlorideEML 26Sodium hydrogen carbonate EML 26Sodium lactate compd solution EML 26Sodium stibogluconateEML 6 5 2SpironolactoneEML 12; EML 16Sulfadoxine pyrimethamineEML 6 5 3Sulfamethoxazole trimethoprimEML 6 2Suramin sodiumEML 6 5 4Suxamethonium (succinylcholine)EML 20Syphilis Rapid Diagnostic Test (RDT)EML 0TerbinafineEML 13TetracaineEML 21TetracyclineEML 21ThiopentalTimololEML 1 1EML 21Product NameEML Category Number(s)TinidazoleEML 6 5 1Tranexamic acidEML 10TriclabendazoleEML 6 1TrimethoprimEML 6 2TropicamideEML 14Valproic acidEML 5;EML 24VecuroniumEML 20VerapamilEML 12WarfarinEML 10Water
Medical Commodities: A collective term to include pharmaceuticals, consumable medical supplies, and durable medical equipment. Medical Equipment (Durable): This term refers to commodities designed for humans or animals that may generally be reused after proper cleaning and disinfection. Medical equipment includes but is not limited to
August 2, 2021 15 August 2, 2021 16 August 2, 2021 17 August 3, 2021 18 August 4, 2021 19 August 5, 2021 20 August 6, 2021 21 August 9, 2021 22 August 9, 2021 23 August 9, 2021 24 August 10, 2021 25 August 11, 2021 26 August 12, 2021 27 August 13, 2021 28 August 16, 2021 29 August 16, 2021 30 August 16, 2021 31
Creating a table of contents The Insert Index/Table window (Figure 1) has five tabs. All of them can be used when creating a table of contents: Use the Index/Table tab to set the attributes of the table of contents. Use the Entries and Styles tabs to format the entries in the table of contents. Use the Background tab to add color or a graphic to the background of the table of
EU Tracker Questions (GB) Total Well Total Badly DK NET Start of Fieldwork End of Fieldwork 2020 15/12/2020 16/12/2020 40 51 9-11 08/12/2020 09/12/2020 41 47 12-6 02/12/2020 03/12/2020 27 57 15-30 26/11/2020 27/11/2020 28 59 13-31 17/11/2020 18/11/2020 28 60 12-32 11/11/2020 12/11/2020 28 59 12-31 4/11/2020 05/11/2020 30 56 13-26 28/10/2020 29/10/2020 29 60 11-31
To reflect Changes in Table GEN I-1, Table AOP I-1, Table ATM I-1 2 July 2019 . 4 July 2019 ; 19/05 GEN/AOP/ATM /SAR ICAO Secretariat, Kazakhstan To reflect Changes in Table GEN I-1, Table AOP I-1, Table ATM I-1, Table SAR I-1 . 15 August 2019 ; 20 August 2019 . 19/07 GEN/ATM ; Norway . To reflect Changes in Table GEN I-1, Table ATM I-1,
Cadillac Escalade, Escalade ESV 2020 2020 Cadillac XT4 2020 2020 Cadillac XT5 2020 2020 Chevrolet Blazer 2019 2020 Chevrolet Express 2018 2021 Chevrolet Silverado 1500 2018 2020 Chevrolet Suburban 2020 2020 Chevrolet Tahoe 2020 2020 Chevrolet Traverse 2020 2020 GMC Acadia 2019 2020 GMC Savana 2018 2021
August 2nd—Shamble "Queen of the Green" August 9th—President's Club (Eclectic Week 1) August 16th—President's Club (Eclectic Week 2) August 23rd—Criss-Cross (1/2 Handicap) August 30th—Stroke Play (HSTP Qualifying) August Play Schedule August Theme — Queen of the Green! P utting prodigies, our next General Meeting and theme day is August
Creating a table of contents The Insert/Index Table window has five tabs. Four of them are used when creating a table of contents: Use the Index/Table tab to set the table's attributes. Use the Entries and Styles tabs to format the table entries. Use the Background tab to add color or a graphic to the table background. The next four sections of this chapter tell you how to use each . /p div class "b_factrow b_twofr" div class "b_vlist2col" ul li div strong File Size: /strong 554KB /div /li /ul ul li div strong Page Count: /strong 15 /div /li /ul /div /div /div
Word. Modifying the appearance To change how the table of contents looks – font type, size, indentation etc. – click in the table and on Table of Contents on the References tab, then choose Custom Table of Contents again. In the Table of Contents dialog box, click the Modify button to
